Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 16, Number 4—April 2010

Research

Livestock-associated Methicillin-Resistant Staphylococcus aureus Sequence Type 398 in Humans, Canada

George R. Golding, Louis Bryden, Paul N. Levett, Ryan R. McDonald, Alice Wong, John Wylie, Morag R. Graham, Shaun Tyler, Gary Van Domselaar, Andrew E. Simor, Denise Gravel, and Michael R. MulveyComments to Author 
Author affiliations: National Microbiology Laboratory, Winnipeg, Manitoba, Canada (G.R. Golding, L. Bryden, M.R. Graham, S. Tyler, G. Van Domselaar, M.R. Mulvey); Saskatchewan Disease Control Laboratory, Regina, Saskatchewan, Canada (P.N. Levett, R.R. McDonald); Royal University Hospital, Saskatoon, Saskatchewan, Canada (A. Wong); Cadham Provincial Laboratories, Winnipeg (J. Wylie); Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada (A.E. Simor); Public Health Agency of Canada, Ottawa, Ontario, Canada (D. Gravel)

Main Article

Table 2

Antimicrobial drug susceptibility of the clinical isolates of methicillin-resistant Staphylococcus aureus sequence type 398, Canada, 2008*

Drug Susceptibility, μg/mL
07 BA 06477 08 BA 02176 08 BA 08100 08 BA 13895 08 BA 22334 T40929
Clindamycin <0.25 <0.25 <0.25 <0.25 <0.25 <0.25
Vancomycin 0.5 0.5 0.5 0.5 0.5 0.5
Erythromycin 0.5 0.5 0.5 0.5 0.5 0.5
SXT <0.25 <0.25 <0.25 <0.25 <0.25 <0.25
Synercid 0.5 1 <0.25 <0.25 <0.25 <0.25
Nitrofurantoin <32 <32 <32 <32 <32 <32
Tetracycline >16 >16 >16 ≤2 >16 >16
Ciprofloxacin 0.5 0.25 0.5 0.25 0.5 0.5
Rifampin <0.25 <0.25 <0.25 <0.25 <0.25 <0.25
Fusidic acid 0.25 0.12 0.25 0.12 0.12 0.12
Linezolid 2 2 2 1 0.5 0.5
Gentamicin 1 1 1 1 ≤0.5 1
Mupirocin 0.5 0.25 <0.12 <0.12 0.25 <0.12

*SXT, sulfamethoxazole/trimethoprim.

Main Article

TOP